See LEGEND for key to shading and symbols.
Subject Area - PHAR Term - Term 1 2020
| PHAR3102 | PHAR3111 | PHAR3251 | PHAR9101 | PHAR9113 | PHAR9114 |
| PHAR9116 | PHAR9124 |
Data is correct as at Sun 27 Sep 19:03:48 AEST 2020
| Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
| PHAR3102 | Molecular Pharmacology | ||||||
| CRS | CR01 | 2005 | Open | 0/15 | 0% | (Course Enrolment, UGRD) | |
| LAB | F10A | 8150 | Enr | Full | 34/34 | 100% | Tue 10-13 (w11, Wurth 120); Fri 10-13 (w1-7,9-10, Wurth 120) |
| LAB | F14A | 8153 | Enr | Open | 19/34 | 56% | Tue 14-17 (w11, Wurth 120); Fri 14-17 (w1-7,9-10, Wurth 120) |
| LEC | A | 8149 | Rel | Open | 53/68 | 78% | Mon 10 (w1-8,10-11, MathewsThC); Tue 09 (w1-10, MathewsThC) |
| TUT | T12A | 8151 | Rel | Open | 27/34 | 79% | Tue 12 (w1-10, Biosci G07) |
| TUT | T13A | 8152 | Rel | Open | 26/34 | 76% | Tue 13 (w1-10, Biosci G07) |
| PHAR3111 | Clinical Pharmacology for HESC | ||||||
| CRS | CR01 | 2926 | Open | 0/7 | 0% | (Course Enrolment, UGRD) | |
| LAB | H11A | 9895 | Enr | Open | 82/88 | 93% | Thu 11-14 (w1-10, Wurth 115) |
| LEC | A | 9894 | Rel | Open | 82/88 | 93% | Tue 09 (w11, MathewsThD); Wed 09 (w1-10, MathewsThD); Thu 09 (w1-10, MathewsThD); Fri 09 (w1-7,9-10, MathewsThD) |
| TUT | W10A | 9896 | Rel | Open | 39/44 | 89% | Wed 10 (w1-10, Mat 105) |
| TUT | W11A | 9897 | Rel | Open | 43/44 | 98% | Wed 11 (w1-10, Mat 105) |
| PHAR3251 | Clinical & Exp'l Pharmacology | ||||||
| CRS | CR01 | 2152 | Open | 0/10 | 0% | (Course Enrolment, UGRD) | |
| LAB | M11A | 5834 | Enr | Open | 54/64 | 84% | Mon 11-14 (w1-8,10-11, Wurth 115) |
| LEC | A | 5831 | Rel | Open | 54/64 | 84% | Mon 09 (w1-8,10-11, MathewsThD); Thu 14 (w1-10, CLB 3) |
| TUT | H15A | 5832 | Rel | Full | 32/32 | 100% | Thu 15 (w1-10, Mat 227) |
| TUT | H16A | 5833 | Rel | Open | 22/32 | 69% | Thu 16 (w1-10, Mat 227) |
| PHAR9101 | Intro to Therapeutics Industry | ||||||
| CRS | CR01 | 1546 | Open | 0/9 | 0% | (Course Enrolment, PGRD) | |
| DST | DST1 | 10939 | Enr | Open | 21/30 | 70% | |
| PHAR9113 | InternationalRegulatoryAffairs | ||||||
| CRS | CR01 | 1436 | Closed | 0/0 | N/A | (Course Enrolment, PGRD) | |
| DST | DST1 | 10940 | Enr | Closed | 0/10 | 0% | |
| PHAR9114 | HTA | ||||||
| CRS | CR01 | 1287 | Open | 0/7 | 0% | (Course Enrolment, PGRD) | |
| DST | DST1 | 10941 | Enr | Open | 23/30 | 77% | |
| PHAR9116 | Clinical Trial Management | ||||||
| CRS | CR01 | 1209 | Open | 0/2 | 0% | (Course Enrolment, PGRD) | |
| DST | DST1 | 10942 | Enr | Open | 8/10 | 80% | |
| PHAR9124 | Internship | ||||||
| CRS | CR01 | 1141 | Open* | 0/5 | 0% | (Course Enrolment, PGRD) | |
| DST | DST1 | 10989 | Enr | Open | 0/5 | 0% | |
| ^ top ^ | |||||||
| LEGEND | |||||||
| * This class requires consent. Students cannot self-enrol. | |||||||
| # Timetable clash allowed. | |||||||
| /odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
| Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
| Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
| [ ] Class capacity where different from effective capacity. | |||||||
| Shaded cells: | LEC | Activity different from previous | |||||
| Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
| 100% | Class is full (> 100% means capacity is exceeded) | ||||||
| 80% | Class is nearly full (80% or more) | ||||||
| 50% | Class is half full | ||||||
| 0% | Class is less than half full | ||||||
| UNSW Sydney NSW 2052, Australia Telephone: (within Aust.) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G ABN: 57 195 873 179 Authorised by Vice-President and Deputy Vice-Chancellor (Academic) Privacy Policy Copyright & Disclaimer Accessibility |